1、 95 ( + ) 48 ( + + ) 47 (ELISA) (OPG) - - , Oswestry (ODI) (VAS) , IL- (P0.05) 1.3 ( ) ( ) , 1 , 21 d d3 ( ) , 1 , 1 D ( ) , , 500 U 8, ( 36 , 0.5 ) , , 1530 mm, , G6805-2A , 10 Hz , 30 min, 1 , 6 , 3 , , 510 , ( 1 , 21 d 1.4 (ELISA) (OPG) - (IL- Oswestry (ODI) (VAS) 9 ODI , 9 : 9 ODI , ODI 10 VAS ,
2、 1 010 , 0 , 13 , 47 , 89 , 10 , VAS , ODI VAS 21 d 1.5 : 11 :X , : : , : , , = ( + ) / 1.6 SPSS17.0 , t ; , P0.05) 21 d , IL- (P0.05) ; IL- (P0.05) , OPG (P0.05) , (P0.05) 1 OPG IL- 2.2 ODI VAS 2 ODI VAS (P0.05) , (P0.05) 2 ODI VAS ( 2.3 3 (P0.05) 3 (n) 3 , , 12-13 , , , 14-15 , 16 IL- IL- , 17 , ,
3、 21 d , OPG (P0.05) , IL- ODI VAS (P0.05) , , IL- , , , IL- , , 18 OPG, OPG , , 19 , IL-1 , , , 20 OPG , , , , 21 , OPG , , , , , , , , , ODI VAS , , , 1 , , , . J. , 2015, 12 (1) :33-36. 2 , , , . J. , 2015, 31 (4) :4-6. 3 , , , . J. , 2015, 24 (2) :303-305. 4 , . J. , 2014, 23 (6) :1138-1139. 5 ,
4、, , . J. , 2014, 13 (1) :154-157. 6 , , , . A J. , 2016, 32 (4) :4-6. 7 , , , . ( 3 ) J. , 2014, 20 (9) :1007-1010. 8 . M. : , 2007:60-61. 9 , . J. , 2012, 27 (8) :760-762. 10Fritz JM, Irrgang JJ.A comparison of a modified oswestry low back pain disability questionnaire and the quebec back pain disa
5、bility scaleJ.Phys Ther, 2001, 81 (2) :776-788. 11 , . J. , 2014, 23 (6) :1138-1139. 12 , . J. , 2014, 34 (3) :565-556. 13 , . J. , 2016, 6 (4) :172-175. 14 , , , . J. , 2014, 33 (3) :274-277. 15 , , , . J. , 2014, 35 (30) :6751-6752. 16 , . J. , 2016, 32 (3) :193-194. 17 , . IL-6 J. , 2007, 13 (10)
6、 :62-63. 18 , . 1 J. , 2008, 6 (12) :1275-1279. 19Wagner D, Fahrleitner-Pammer A.Levels of osteoprotegerin (OPG) and receptor activator for nuclear factor kappa B ligand (RANKL) in serum:are they of any helpJ.Wien Med Wochenschr, 2010, 160 (17-18) :452-457. 20 . J. , 2016, 48 (7) :134-136. 21 , , , . OPG/RANKL IL-17 J. , 2012, 28 (4) :330-333.
